Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues
... Association (DIA), in collaboration with the FDA, oligonucleotide Therapeutics Society, Health Canada, and the ... (DIA)]], in collaboration with the FDA, oligonucleotide Therapeutics Society, Health Canada, and the ... Dependent Oligonucleotides Antisense oligonucleotide Discovery and Development ...Orochem Technologies Acquires Oligonet, a Custom Oligo Synthesis Business
... markets today announced the acquisition of Oligonet, Inc. a Custom oligonucleotide Synthesis Business located in Gaithersburg, MD. With this acquisition, ... player in the custom oligo synthesis market having already been supporting oligonucleotide synthesis establishment with several products that range from synthesis ...MWG and Operon Are Joining Forces
... in order to create a new worldwide leader in the competitive custom oligonucleotide market. With about $US 50M in revenue and state of the art high-throughput ... years overcapacity in the market has put a lot of pressure on all custom oligonucleotide synthesis service suppliers. Prices have decreased to a level where very ...Another LNA-based RNA Inhibitor Enters Clinical Trials
... LNA-based PIK3CA antagonist" "EZN-3042, a novel locked nucleic acid oligonucleotide against survivin, inhibits survivin expression and confers taxol sensitivity" "EZN-3920, an LNA antisense oligonucleotide RNA antagonist, down modulates HER3 expression and PI3K/Akt signaling ...Quark Pharmaceuticals Presents at Asia TIDES Conference
... Ph.D., Vice President, Pharmaceutical Development presented an overview of Quark's novel pipeline of synthetic siRNA compounds at the Asia TIDES oligonucleotide and Peptide(R) Technology and Product Development Conference, held February 24th, 2009 in Tokyo, Japan. Dr. Thompson's presentation, entitled ...ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
... provide login details on its website http://www.antisense.com.au once these are confirmed. Conference abstract follows: VLA-4 Antisense - An oligonucleotide targeting VLA-4 mRNA (ATL1102) significantly reduces new active lesions in patients with RR-MS Volker Limmroth(1), Frederik Barkhof(2), Nuket ...Genta Clinical Programs Featured at American Society of Hematology Meeting
... featured press briefing sponsored by ASH on Sunday December 9 at 9:30 am. -- Oblimersen (Genasense(R)), a phosphorothioate Bcl-2 antisense oligonucleotide (ASO), can be safely administered by bolus subcutaneous (SC) injection and brief IV Infusion. Publication. -- Phase 1 assessment of G4544, an ...Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
... (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in ...A new gene silencing platform -- silence is golden
... polyA tail addition in a gene specific manner. Further, the domains of the oligonucleotide are independent so transcript binding and U1 snRNP binding can be ... used 5'-end-mutated U1 snRNA," Gunderson explained. "The U1 Adaptor is an oligonucleotide version of this older method and instead targets the 3' end processing ...Leroy Hood to receive 2008 Pittcon Heritage Award
... genomics: the DNA and protein sequencers and synthesizers and the ink-jet oligonucleotide synthesizer. The DNA sequencer in particular has revolutionized genomics ... at the University of Washington, where he developed the ink-jet oligonucleotide synthesizer, which synthesizes DNA chips, and initiated systems studies on ...ISU researchers find possible treatment for spinal muscular atrophy
... because of the presence of a specific intronic sequence in the gene or DNA. To make SMN2 behave as SMN1, Singh has introduced a small antisense oligonucleotide that blocks this specific intronic sequence. When the intronic sequence is blocked, SMN2 produces normal proteins and acts, in effect, like SMN1. ...Strong immune response to new siRNA drugs in development may cause toxic side effects
... Inc. (www.liebertpub.com) The article is available free online at www.liebertpub.com/oli siRNAs are duplex structures comprised of short oligonucleotide sequences. The discovery that naturally occurring and synthetic siRNAs can effectively prevent expression of a disease gene sparked intense interest ...Researchers take first look at the genetic dynamics of inbreeding depression
... researchers also crossed the three highest inbred lines to one another, creating outbred lines that could be compared with the inbred ones. Using oligonucleotide microarrays, which can measure the activity of all of an organism's genes at once, the researchers were able to see which genes were more or less ...Less can be more, for plant breeders too
... crops and it may provide an important new avenue to enhance agronomic performance and nutritional value. Computer software to design the required oligonucleotide sequences and detailed protocols to produce amiRNAs are provided free of charge on the authors web site, at http://wmd2.weigelworld.org. Similarly, ...A New Era in the Application of Lab-on-a-Chip to Rapid Point-of-Care Diagnosis
... highly advanced nucleic acid sequence-based amplification - enzyme-linked oligonucleotide capture (NASBA-EOC). The VDS technology has an advantage of not requiring ... with a choice of technology platforms, either NASBA-EOC (enzyme-linked oligonucleotide capture) or a recently developed, patented and validated NASBA-POC ...Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Based Therapeutics
... the National Institutes of Health (NIH) for up to $1.5 million to design oligonucleotide drugs that can exploit the RNA interference (RNAi) antisense mechanism for ... support from the NIH in our ongoing efforts to apply our RNA technologies, oligonucleotide chemistries and expertise to exploit antisense mechanisms, such as RNAi, ...SEQUENOM Announces Launch of MassARRAY Compact 96 System
... gene expression analysis, quantitative methylation marker analysis, comparative sequence analysis of haploid organisms, SNP discovery, and oligonucleotide quality control. About SEQUENOM SEQUENOM is a life sciences company committed to providing the best genetic analysis products that ...HEEBO Human Genome Set 200 pmol from Invitrogen
Description:... Genome Set and MEEBO (Mouse Exonic Evidence Based oligonucleotide ) Genome Set contain a collection of open source ... Genome Set contains 48,958 70mer 5 amino modified oligonucleotide probes in 128 384-well plates. The set includes ... MEEBO set contains 38,467 70mer 5 amino modified oligonucleotide probes in 101 384-well plates. The set includes ...Custom 60-mer Oligonucleotide Microarrays from Agilent Technologies
Description:... slide) or 22,575 features per array (1 array/slide). Features 60-mer oligonucleotide probe length - This extended length delivers higher sensitivity compared ... 1 microarray/slide Probes arrayed on 1" x 3" glass slides - oligonucleotide probes are arrayed on glass slides designed for optimal results in the ...Oligo Synthesis from Biosearch Technologies
Description:... Since the early 80s Biosearch Technologies has been at the forefront providing advanced oligonucleotide tools to accelerate the discovery and application of genomic information. Whether you need dual-labeled FRET probes and primers or 100 or 100,000 ...Amplifluor UniPrimer II Fluorescein from CHEMICON
Description:... is a hairpin primer labeled with a fluorescent energy transfer pair (fluorescein and non-fluorescent quencher) and a 3 single-stranded oligonucleotide tail. The UniPrimer is identical to the UniPrimer provided in the Amplifluor Universal Detection System (S7901) and is provided at a concentration ...